T. Rowe Price Associates’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $3.52M | Sell |
|
|||||
|
2019
Q3 | $4.81M | Sell |
|
|||||
|
2019
Q2 | $6.59M | Sell |
|
|||||
|
2019
Q1 | $7.9M | Sell |
|
|||||
|
2018
Q4 | $7.29M | Sell |
|
|||||
|
2018
Q3 | $17.1M | Sell |
|
|||||
|
2018
Q2 | $22M | Sell |
|
|||||
|
2018
Q1 | $23.1M | Buy |
|
|||||
|
2017
Q4 | $3.17M | Buy |
|
|||||
|
2017
Q3 | $4.88M | Sell |
|
|||||
|
2017
Q2 | $4.17M | Sell |
|
|||||
|
2017
Q1 | $16.5M | Buy |
|
|||||
|
2016
Q4 | $8.76M | Sell |
|
|||||
|
2016
Q3 | $10.5M | Buy |
|
|||||
|
2016
Q2 | $8.8M | Sell |
|
|||||
|
2016
Q1 | $8.95M | Buy |
|